Home › Funds › Kryger Capital LLC › APGE
Kryger Capital LLC position in APGE
APOGEE THERAPEUTICS INC
Kryger Capital LLC reported holding 742,555 shares of APGE (APOGEE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$98.6M, representing 5.62% of its reported portfolio and ranking #8 among its reported holdings. Kryger Capital LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Kryger Capital LLC's APGE position evolved
Kryger Capital LLC first disclosed a stake in APGE in Q2 2026 at 742,555 shares (US$98.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 742.55K | $98.56M | New |
About APGE and 13F data
APGE (APOGEE THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 59 other funds we track also report a position in APGE — the largest reported positions include Venrock Adviser, LLC (US$1.13B), HBK INVESTMENTS L P (US$378.3M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$231.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding APGE
- Venrock Adviser, LLC 8.49M sh · $1.13B · Q2 2026
- HBK INVESTMENTS L P 2.85M sh · $378.28M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.74M sh · $230.96M · Q2 2026
- GLAZER CAPITAL, LLC 1.64M sh · $217.82M · Q2 2026
- Paradigm Biocapital Advisors LP 1.58M sh · $209.23M · Q2 2026
- Pentwater Capital Management LP 1.43M sh · $189.14M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.31M sh · $173.63M · Q2 2026
- Affinity Asset Advisors, LLC 987.00K sh · $131.00M · Q2 2026
- First Light Asset Management, LLC 930.29K sh · $123.48M · Q2 2026
- First Trust Capital Management L.P. 625.18K sh · $82.98M · Q2 2026
- Remedium Capital Partners, LLC 586.69K sh · $77.87M · Q2 2026
- Soros Fund Management 564.50K sh · $74.93M · Q2 2026
More on Kryger Capital LLC
FAQ
How long has Kryger Capital LLC held APGE?
Kryger Capital LLC has disclosed APGE holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Kryger Capital LLC's current position in APGE?
As of Q2 2026, Kryger Capital LLC holds 742.55K shares of APGE (APOGEE THERAPEUTICS INC), valued at $98.56M, representing 5.62% of its reported portfolio and ranking #8.
Has Kryger Capital LLC been buying or selling APGE?
In the latest 13F filing (Q2 2026), Kryger Capital LLC newly opened its position in APGE.
Which other funds hold APGE?
Other major institutional holders of APGE include Venrock Adviser, LLC, HBK INVESTMENTS L P, DRIEHAUS CAPITAL MANAGEMENT LLC, among 59 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.